Brokerages Set Benefytt Technologies Inc (NASDAQ:BFYT) PT at $31.00

Share on StockTwits

Shares of Benefytt Technologies Inc (NASDAQ:BFYT) have been assigned a consensus rating of “Hold” from the seven research firms that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and six have given a hold recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $31.00.

A number of research analysts have recently weighed in on BFYT shares. Cantor Fitzgerald restated a “neutral” rating and set a $31.00 price target on shares of Benefytt Technologies in a report on Monday, July 13th. SVB Leerink downgraded shares of Benefytt Technologies from an “outperform” rating to a “market perform” rating and set a $31.00 price target on the stock. in a report on Tuesday, July 14th. Zacks Investment Research upgraded shares of Benefytt Technologies from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 7th. Canaccord Genuity downgraded shares of Benefytt Technologies from a “buy” rating to a “hold” rating and cut their price target for the company from $49.00 to $31.00 in a report on Tuesday, July 14th. Finally, ValuEngine upgraded shares of Benefytt Technologies from a “strong sell” rating to a “sell” rating in a research note on Monday, August 3rd.

NASDAQ:BFYT traded up $0.03 during trading hours on Tuesday, reaching $31.00. 354,700 shares of the company’s stock were exchanged, compared to its average volume of 721,063. Benefytt Technologies has a 12 month low of $15.60 and a 12 month high of $31.49. The company has a debt-to-equity ratio of 2.52, a current ratio of 1.32 and a quick ratio of 1.32. The stock has a market cap of $442.30 million, a P/E ratio of -14.69 and a beta of 1.24. The stock has a 50-day moving average price of $30.99.

Benefytt Technologies (NASDAQ:BFYT) last released its quarterly earnings results on Monday, August 10th. The company reported ($0.14) earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.26). The business had revenue of $52.11 million for the quarter, compared to the consensus estimate of $50.45 million. Benefytt Technologies had a negative net margin of 7.13% and a positive return on equity of 33.74%. On average, sell-side analysts forecast that Benefytt Technologies will post 2.63 EPS for the current year.

Large investors have recently bought and sold shares of the stock. AXA acquired a new stake in Benefytt Technologies in the 1st quarter worth $237,000. State Street Corp acquired a new stake in Benefytt Technologies in the 1st quarter worth $4,347,000. Geode Capital Management LLC acquired a new stake in Benefytt Technologies in the 1st quarter worth $3,515,000. Alliancebernstein L.P. acquired a new stake in Benefytt Technologies in the 1st quarter worth $1,672,000. Finally, Nuveen Asset Management LLC acquired a new stake in Benefytt Technologies in the 1st quarter worth $3,174,000. Institutional investors and hedge funds own 98.86% of the company’s stock.

About Benefytt Technologies

Benefytt Technologies, Inc engages in the distribution of individual and family health insurance plans. It operates through the following segments: Medicare Segment and IFP Segment. The Medicare Segment includes offering of Medicare-related health insurance plans. The IFP Segment includes individual and family health insurance plans (“”IFP””), short-term medical (“”STM””) insurance plans, health benefit insurance plans (“”HBIP””) and supplemental products which include a variety of additional insurance and non-insurance products.

Read More: Initial Coin Offering (ICO)

Analyst Recommendations for Benefytt Technologies (NASDAQ:BFYT)

Receive News & Ratings for Benefytt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Benefytt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply